newflink@nsnewf.org

Northstar Newfoundland Club

View all threads

Fwd: Canine Cystinuria Clinical Trial: Updated Information

MM
Missy Manke
Mon, Jun 25, 2018 2:24 PM

See below if anyone is interested.

Missy
Sent from my iPhone

Begin forwarded message:

From: Marissa Farbo mfarbo@animalci.com
Date: June 25, 2018 at 9:04:56 AM CDT
Subject: Canine Cystinuria Clinical Trial: Updated Information

Hello, Newfoundland Lover!

We are writing to you in search of Newfoundlands with cystinuria, a type of kidney disease more prevalent in certain breeds of dogs. We are helping to develop a drug for this disease and are looking for dogs to participate in a simple study.

The study has been initiated and we have several spots still available for participation.

Trial Specifics

The trial involves only one veterinary visit that is funded by the trial. The rest of the trial activities occur at home. The trial will involve administration of 2 oral treatments, in tablet form, over the course of 1 day (also called “one dosing period”). During this time, urine samples will be collected. The samples will then be sent in one shipment to a laboratory. Shipping and sample collection materials are provided by the trial. This process will be replicated a total of four times (four dosing periods). The therapies involved are not expected to cause dogs any pain or distress, and the study can be conducted at home, and on a schedule that is convenient for you. Successful completion of the first two dosing periods will result in a $500 honorarium. Completion of the second two will result in an additional $250 honorarium, for a total of $750. It is hoped that these and other studies will result in an FDA approved therapy for dogs with cystinuria. More details will be disclosed under a confidentiality agreement.

Trial Eligibility

Dogs must weigh at least 20kg (45lb).  Dogs must be diagnosed with cystinuria, but otherwise healthy. A short visit to any veterinarian to get your dog’s weight and confirm general good health will be required. Trial medications must be given in a way that ensures they are swallowed. The use of a Pill Pocket, or the like, is recommended.

Locations

Any US veterinarian for a pre-trial checkup as long as the veterinarian is willing to participate.

Anyone interested to learn more can contact Marissa Farbo at mfarbo@animalci.com at their earliest convenience.

Would you please forward this email to your general membership or to specific owners of dogs with cystinuria?

Thank you very much.

Your friends at ACI

(http://www.animalci.com)

--

Marissa Farbo • Study Monitor and Clinical Research Associate
4445 Willard Ave, Sixth Floor • Chevy Chase, MD, 20815
cell: 774.272.0493
www.animalci.com

ACI has moved! Please note our new corporate address above.

Confidentiality Notice: This electronic mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. This message is a private communication. If you are not the intended recipient, please do not read, copy, or use it, and do not disclose it to others. Please notify the sender of the delivery error by replying to this message, and then delete it from your system. Thank you.

See below if anyone is interested. Missy Sent from my iPhone Begin forwarded message: > From: Marissa Farbo <mfarbo@animalci.com> > Date: June 25, 2018 at 9:04:56 AM CDT > Subject: Canine Cystinuria Clinical Trial: Updated Information > > Hello, Newfoundland Lover! > > We are writing to you in search of Newfoundlands with cystinuria, a type of kidney disease more prevalent in certain breeds of dogs. We are helping to develop a drug for this disease and are looking for dogs to participate in a simple study. > > *The study has been initiated and we have several spots still available for participation.* > > Trial Specifics > > The trial involves only one veterinary visit that is funded by the trial. The rest of the trial activities occur at home. The trial will involve administration of 2 oral treatments, in tablet form, over the course of 1 day (also called “one dosing period”). During this time, urine samples will be collected. The samples will then be sent in one shipment to a laboratory. Shipping and sample collection materials are provided by the trial. This process will be replicated a total of four times (four dosing periods). The therapies involved are not expected to cause dogs any pain or distress, and the study can be conducted at home, and on a schedule that is convenient for you. Successful completion of the first two dosing periods will result in a $500 honorarium. Completion of the second two will result in an additional $250 honorarium, for a total of $750. It is hoped that these and other studies will result in an FDA approved therapy for dogs with cystinuria. More details will be disclosed under a confidentiality agreement. > > Trial Eligibility > > Dogs must weigh at least 20kg (45lb). Dogs must be diagnosed with cystinuria, but otherwise healthy. A short visit to any veterinarian to get your dog’s weight and confirm general good health will be required. Trial medications must be given in a way that ensures they are swallowed. The use of a Pill Pocket, or the like, is recommended. > > Locations > > Any US veterinarian for a pre-trial checkup as long as the veterinarian is willing to participate. > > Anyone interested to learn more can contact Marissa Farbo at mfarbo@animalci.com at their earliest convenience. > > > > > > Would you please forward this email to your general membership or to specific owners of dogs with cystinuria? > > Thank you very much. > > Your friends at ACI > > (http://www.animalci.com) > > > > -- > > > > > > > Marissa Farbo • Study Monitor and Clinical Research Associate > 4445 Willard Ave, Sixth Floor • Chevy Chase, MD, 20815 > cell: 774.272.0493 > www.animalci.com > > ACI has moved! Please note our new corporate address above. > > Confidentiality Notice: This electronic mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. This message is a private communication. If you are not the intended recipient, please do not read, copy, or use it, and do not disclose it to others. Please notify the sender of the delivery error by replying to this message, and then delete it from your system. Thank you. >